Draft Scoping Document for the Assessment of Alzheimer’s Disease Posted by ICER
Yesterday the Institute for Clinical and Economic Review (ICER) posted a Draft Scoping Document detailing the planned review of the comparative clinical effectiveness [...]
FDA Approved NDA for KOSELUGO™ (selumetinib)
Recently the FDA approved AstraZeneca’s KOSELUGO™ (selumetinib) for treatment of pediatric patients two years of age and older with neurofibromatosis [...]
Pfizer Seeks Judgment Favoring Proposed Patient-assistance Programs
If Pfizer wins their lawsuit against the U.S. government, Medicare stands to spend much, much more on some drugs. Pfizer [...]
Thomas Wilke Weighs In On Health Economics and Real-World Evidence Studies
In this interview, Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), discusses his background and experience in HEOR to [...]
Lessons Learned from COVID-19 Health Preference Research
The COVID-19 pandemic caused a major shift in the lives of many HEOR researchers, especially those conducting health preference research. [...]
Building a More Consumer-Centric Future in the Era of COVID
The urgent need to scale healthcare innovation has been unmasked by the COVID-19 pandemic, making consumerism an essential tenet of [...]
Beyond Real-World Data and COVID-19
Join Casey Ross and other industry leaders as they discuss applications of real-world data in the battle against Covid-19. In [...]
[Podcast] The MM+M Podcast: FDA’s Bakul Patel
Bakul Patel has been leading regulatory and scientific efforts related to digital health devices at the FDA since 2010. Tune [...]
What Does the Rise of Real-World Evidence Mean For Pharma?
The COVID-19 pandemic has highlighted the urgent need for real-world evidence to inform decision making. This month’s issue of ISPOR [...]
Unlocking the Promise of Real-World Evidence
At present, researchers have an abundance of real-world data. Although these data have been primarily used for safety surveillance, they [...]
Updates From the Real-World Evidence Transparency Initiative
The ISPOR Real-World Evidence (RWE) Transparency Initiative moves forward towards the Society’s goals while underscoring the need for transparency in [...]
[ebook] Version 4.1 of the AMCP Format: Product Dossiers
On December 23, 2019, the Academy of Managed Care Pharmacy (AMCP) released Version 4.1 of the AMCP Format for Formulary [...]
Accountable Care Organizations Generate $1.19 billion in Savings to Medicare
CMS recently announced that accountable care organizations generated $1.19 billion in total net savings to Medicare in 2019, proving the [...]
Dascena’s COViage Receives Emergency Use Authorization from FDA
The FDA issued an Emergency Use Authorization to a clinical decision support (CDS) tool that predicts when hospitalized COVID patients [...]
High Standards Needed to Inspire Trust in Digital Health Companies
Digital health companies are making big promises about affordability, access, prevention, early detection and intervention. Proponents claim that these companies [...]
[Webinar] Driving Value and Sustainable Health Care Economics Through Consumer Engagement
Tune in to this on-demand webinar to hear industry leaders David Wichmann, CEO, UnitedHeath Group, Laura Kaiser, President & CEO, [...]
ICER Releases Final Report and Policy Recommendations for Ulcerative Colitis Treatments
The Institute for Clinical and Economic Review (ICER) recently released a Final Evidence Report and Report-at-a-Glance evaluating comparative clinical effectiveness and value of the [...]
ICER Publishes Evidence Report on Therapies for Hemophilia A
Today the Institute for Clinical and Economic Review (ICER) released a report concluding that compared to common current dosing levels [...]
How is it Possible For an X-ray Price to Be Unknowable? Convenience!
On Thursday a panel of three judges heard oral arguments in a case that could usher in a great many [...]
Has Value-based Care Truly Moved the Needle?
Humana recently published a report stating that Medicare Advantage members covered by value-based care (VBC) arrangements have better outcomes and lower [...]
[Webinar] COVID-19: The Biggest Challenge to Cold Chain Supply Disruption Ever
Distributing and deploying a COVID-19 vaccine remains a great challenge filled with uncertainty as to the initial results, stability data [...]
Will more journals start charging submission fees?
COVID-19 has negatively impacted research and library budgets and reduced available funds for subscriptions and article processing charges (APCs). The downstream impacts [...]
Trump Seeks to Send Seniors $8 Billion in Drug Discount Cards on Eve of Election
Yesterday The Washington Post provided an update on President Trump’s plan to mail $200 drug-discount cards to approximately 40 million Medicare [...]
IQVIA Joins Forces with FDA to Improve Understanding of COVID-19’s Community Impact
IQVIA announced a scientific partnership with the U.S. Food and Drug Administration that will serve to provide timely analytics from [...]
[Podcast] Telehealth, Standardizing Care, and Drug Prices in Oncology With Dr. Vincent Rajkumar
Tune to this podcast for a discussion on telehealth in oncology with Vincent Rajkumar, MD. As he lends his insights [...]